Related Experiment Video
Updated: Jun 4, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Sudden cardiac death in chronic kidney disease: epidemiology and prevention
M Khaled Shamseddin1, Patrick S Parfrey
1Division of Nephrology, Memorial University of Newfoundland, Patient Research Centre, Health Science Centre, St John's, Canada.
Insights
Patients with chronic kidney disease (CKD) face high cardiovascular mortality, with sudden cardiac death increasing with CKD stage. Prevention strategies and cardioverter-defibrillator implantation can reduce this risk.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Patients with chronic kidney disease (CKD) exhibit significantly higher annual cardiovascular mortality compared to the general population.
- Sudden cardiac death (SCD) risk escalates with advancing CKD stages, accounting for up to 60% of cardiac deaths in dialysis patients.
- Cardiac arrest incidence in hemodialysis units is notable, with specific risk factors identified.
Purpose of the Study:
- To summarize the risk factors and potential preventive strategies for sudden cardiac death in patients with chronic kidney disease.
- To highlight the increased risk of cardiac arrest in hemodialysis patients and associated contributing factors.
- To discuss the role of cardioverter-defibrillator implantation in reducing SCD in CKD patients.
Main Methods:
- Review of existing literature on cardiovascular mortality and sudden cardiac death in chronic kidney disease patients.
- Identification and analysis of key risk factors for sudden cardiac death in the CKD population, including those undergoing hemodialysis.
- Evaluation of the efficacy of primary and secondary prevention strategies, including cardioverter-defibrillator implantation.
Main Results:
- Significant risk factors for SCD in CKD include recent hospitalization, blood pressure drops during hemodialysis, duration on dialysis, time since last session, and diabetes mellitus.
- The complex pathophysiological milieu of CKD, involving electrolyte imbalances, inflammation, and sympathetic overactivity, contributes to arrhythmias and SCD.
- Survival rates following cardiac arrest in dialysis patients are notably low, underscoring the need for effective prevention.
Conclusions:
- Cardiovascular mortality, particularly SCD, is a major concern in patients with chronic kidney disease.
- Implementing primary and secondary prevention measures is crucial for reducing SCD and improving outcomes in CKD patients.
- Cardioverter-defibrillator implantation is a viable option for decreasing SCD risk, with implantation decisions guided by patient age and CKD stage.
Abstract:
Annual cardiovascular mortality in patients with chronic kidney disease (CKD) is much higher than in the general population. The rate of sudden cardiac death increases as the stage of CKD increases and could be responsible for 60% of cardiac deaths in patients undergoing dialysis. In hemodialysis units treating patients with CKD, cardiac arrest occurs at a rate of seven arrests per 100,000 hemodialysis sessions. Important risk factors for sudden cardiac death in patients with CKD include hospitalization within the past 30 days, a drop of 30 mmHg in systolic blood pressure during hemodialysis, duration of life on hemodialysis, time since the previous dialysis session, and the presence of concomitant diabetes mellitus. As a result of the adverse cardiomyopathic and vasculopathic milieu in CKD, the occurrence of arrhythmias, conduction abnormalities, and sudden cardiac death could be exacerbated by electrolyte shifts, divalent ion abnormalities, diabetes, sympathetic overactivity, in addition to inflammation and perhaps iron deposition. Impaired baroreflex effectiveness and sensitivity, as well as obstructive sleep apnea, might also contribute to the risk of sudden death in CKD. The likelihood of survival following cardiac arrest is very low in dialysis patients. Primary and secondary prevention of cardiac arrest could reduce cardiovascular mortality in patients with CKD. Cardioverter-defibrillator implantation decreases the risk of sudden death in patients with CKD. The decision to implant a cardioverter-defibrillator should be influenced by the patient's age and stage of CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
